BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7512426)

  • 1. Galanin-(1-15), but not galanin-(1-29), modulates 5-HT1A receptors in the dorsal hippocampus of the rat brain: possible existence of galanin receptor subtypes.
    Hedlund PB; Finnman UB; Yanaihara N; Fuxe K
    Brain Res; 1994 Jan; 634(1):163-7. PubMed ID: 7512426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galanin-(1-16) modulates 5-HT1A receptors in the ventral limbic cortex of the rat.
    Díaz-Cabiale Z; Narváez JA; Finnman UB; Bellido I; Ogren SO; Fuxe K
    Neuroreport; 2000 Feb; 11(3):515-9. PubMed ID: 10718306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centrally coinjected galanin and a 5-HT1A agonist act synergistically to produce vasodepressor responses in the rat.
    Hedlund PB; Aguirre JA; Narvaez JA; Fuxe K
    Eur J Pharmacol; 1991 Oct; 204(1):87-95. PubMed ID: 1725157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of galanin and 5-HT1A receptor coupling to adenylyl cyclase in discrete regions of the rat brain.
    Billecocq A; Hedlund PB; Bolaños-Jiménez F; Fillion G
    Eur J Pharmacol; 1994 Oct; 269(2):209-17. PubMed ID: 7531647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of 5-hydroxytryptamine1A receptors increases the affinity of galanin receptors in di- and telencephalic areas of the rat.
    Hedlund P; von Euler G; Fuxe K
    Brain Res; 1991 Sep; 560(1-2):251-9. PubMed ID: 1836971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for specific N-terminal galanin fragment binding sites in the rat brain.
    Hedlund PB; Yanaihara N; Fuxe K
    Eur J Pharmacol; 1992 Dec; 224(2-3):203-5. PubMed ID: 1281778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galanin (1-15) enhances the antidepressant effects of the 5-HT1A receptor agonist 8-OH-DPAT: involvement of the raphe-hippocampal 5-HT neuron system.
    Millón C; Flores-Burgess A; Narváez M; Borroto-Escuela DO; Santín L; Gago B; Narváez JA; Fuxe K; Díaz-Cabiale Z
    Brain Struct Funct; 2016 Dec; 221(9):4491-4504. PubMed ID: 26792005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential sensitivity of 3H-agonist binding to pre- and postsynaptic 5-HT1A receptors in bovine brain.
    Iben LG; Mahle CD; Yocca FD
    Br J Pharmacol; 1994 Dec; 113(4):1400-6. PubMed ID: 7889298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding and agonist/antagonist actions of M35, galanin(1-13)-bradykinin(2-9)amide chimeric peptide, in Rin m 5F insulinoma cells.
    Kask K; Berthold M; Bourne J; Andell S; Langel U; Bartfai T
    Regul Pept; 1995 Nov; 59(3):341-8. PubMed ID: 8577939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist.
    Jerning E; Svantesson GT; Mohell N
    Eur J Pharmacol; 1998 Nov; 360(2-3):219-25. PubMed ID: 9851589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracisternally injected galanin-(1-15) modulates the cardiovascular responses of galanin-(1-29) and the 5-HT1A receptor agonist 8-OH-DPAT.
    Narváez JA; Diaz Z; Aguirre JA; González-Barón S; Yanaihara N; Fuxe K; Hedlund PB
    Eur J Pharmacol; 1994 May; 257(3):257-65. PubMed ID: 7522172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of the putative galanin receptor antagonists M15 and M35 on striatal acetylcholine release.
    Ogren SO; Pramanik A; Land T; Langel U
    Eur J Pharmacol; 1993 Sep; 242(1):59-64. PubMed ID: 7693496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal galanin fragments inhibit the hippocampal release of acetylcholine in vivo.
    Girotti P; Bertorelli R; Fisone G; Land T; Langel U; Consolo S; Bartfai T
    Brain Res; 1993 May; 612(1-2):258-62. PubMed ID: 7687191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
    Kirchgessner AL; Liu MT; Howard MJ; Gershon MD
    J Comp Neurol; 1993 Jan; 327(2):233-50. PubMed ID: 8425944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor.
    Wynick D; Smith DM; Ghatei M; Akinsanya K; Bhogal R; Purkiss P; Byfield P; Yanaihara N; Bloom SR
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4231-5. PubMed ID: 7683428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galanin receptor and its ligands in the rat hippocampus.
    Fisone G; Langel U; Carlquist M; Bergman T; Consolo S; Hökfelt T; Undén A; Andell S; Bartfai T
    Eur J Biochem; 1989 Apr; 181(1):269-76. PubMed ID: 2469577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
    Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
    Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal galanin-(1-16) fragment is an agonist at the hippocampal galanin receptor.
    Fisone G; Berthold M; Bedecs K; Undén A; Bartfai T; Bertorelli R; Consolo S; Crawley J; Martin B; Nilsson S
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9588-91. PubMed ID: 2594786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical in vitro and in vivo binding of [3H]S-14506 to brain 5-HT1A receptors.
    Lima L; Laporte AM; Gaymard C; Spedding M; Mocaër E; Hamon M
    J Neural Transm (Vienna); 1997; 104(10):1059-75. PubMed ID: 9503258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.